NCT06296433

Brief Summary

The goal of this clinical trial is to test a home-based virtual reality rehabilitation application in patients with chronic low back pain. The main question it aims to answer are: Is a prototype of a novel VR software application effective at reducing pain, improving daily function, improving range of motion, and reducing fear of movement in adult patients with chronic low back pain compared with a passive VR intervention? Participants in the treatment group will use the application daily for 20 minutes for a period of 3 weeks at home and unsupervised. Researchers will compare use of the VR application with a control group that watches 2D video to see if the treatment group have improved pain, disability, range of motion, and fear of movement.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable chronic-pain

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 29, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
26 days until next milestone

Study Start

First participant enrolled

April 1, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 10, 2024

Status Verified

May 1, 2024

Enrollment Period

8 months

First QC Date

February 29, 2024

Last Update Submit

May 9, 2024

Conditions

Keywords

virtual realityembodimentchronic painrehabilitation

Outcome Measures

Primary Outcomes (1)

  • Brief Pain Inventory

    Allows patients to rate the severity of their pain and the degree to which their pain interferes with common dimensions of feeling and function. Minimum score 0, maximum score 70, higher score = worse outcome.

    Baseline, 4 weeks, 8 weeks

Secondary Outcomes (4)

  • Roland-Morris Disability Questionnaire

    Baseline, 4 weeks, 8 weeks

  • Short-Form 12

    Baseline, 4 weeks, 8 weeks

  • Patient Global Impression of Change

    Baseline, 4 weeks, 8 weeks

  • Pain Catastrophization Scale

    Baseline, 4 weeks, 8 weeks

Other Outcomes (3)

  • Spinal Range of motion

    Baseline, 4 weeks, 8 weeks

  • Adherence to treatment

    4 weeks

  • Embodiment

    4 weeks

Study Arms (2)

VR rehabilitation treatment

EXPERIMENTAL

Daily use of VR rehabilitation program independently at home for a period of 3 weeks. Each daily session is 20 minutes.

Other: VR rehabilitation

VR control treatment

PLACEBO COMPARATOR

Daily watching 2D video independently at home using VR headset for a period of 20 minutes.

Other: VR video application

Interventions

VR software application containing education, exergames, therapeutic exercises and relaxation sections.

VR rehabilitation treatment

VR software application that plays 2D nature videos

VR control treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-65 of either sex
  • Diagnosis of chronic low back pain of \>12 weeks, with or without associated somatic referred leg pain
  • Average pain intensity over the previous month ≤7/10 and ≥ 2/10)

You may not qualify if:

  • Spondylolysis, fracture, cauda equina syndrome, active spinal infection
  • Acute radiculopathy or compromised nerve root
  • Recent spinal surgery (\<12 months) or lower limb surgery (\<3 months)
  • Major depressive symptoms as indicated by the Patient Health Questionnaire-2 depression screen score of 4 or more.
  • Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, balance disorder, or other neurological diseases that may prevent the use of virtual reality or adverse effects.
  • Cardiopulmonary or pulmonary disorder with contraindication to physical exercise
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IDIBAPS

Barcelona, 08036, Spain

RECRUITING

MeSH Terms

Conditions

Chronic PainLow Back Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBack Pain

Study Officials

  • Maria V Sanchez-Vives

    Institut d'Investigacions Biomèdiques August Pi i Sunyer

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 29, 2024

First Posted

March 6, 2024

Study Start

April 1, 2024

Primary Completion

November 30, 2024

Study Completion

December 31, 2024

Last Updated

May 10, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Study data will be made available on request from the study authors

Shared Documents
CSR
Time Frame
No time limit. Data will be made available on completion of the trial.
Access Criteria
Email request directly from Principle Investigator, Prof. Maria Sanchez-Vives (msanche3@recerca.clinic.cat)

Locations